title: Treatment of severe refractory adult atopic dermatitis with ustekinumab.
authors.forename: Rafael
authors.initials: R
authors.lastname: Puya
authors.forename: Maria
authors.initials: M
authors.lastname: Alvarez-López
authors.forename: Antonio
authors.initials: A
authors.lastname: Velez
authors.forename: Enrique
authors.initials: E
authors.lastname: Casas Asuncion
authors.forename: José Carlos
authors.initials: JC
authors.lastname: Moreno
mesh_terms: D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D016572:Cyclosporine / Q000627:therapeutic use; D003876:Dermatitis, Atopic / Q000188:drug therapy* / Q000532:radiotherapy; D004485:Eczema / Q000188:drug therapy; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D011241:Prednisone / Q000627:therapeutic use; D011537:Pruritus / Q000188:drug therapy; D012720:Severity of Illness Index; D014467:Ultraviolet Therapy; D000069549:Ustekinumab; D055815:Young Adult
chemical_list: D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D007166:Immunosuppressive Agents; D016572:Cyclosporine; D000069549:Ustekinumab; D011241:Prednisone; C472181:efalizumab